 |
|
0 new discussion posts (4 published)
Sign in to view your progression
|
This E-module on Immunotherapy in gynae-oncology gives the first details of the basic science underlying immunotherapy in gynae cancers (ovarian, endometrial, and cervical cancers) and advise how to manipulate the microenvironment of these malignant tumours. In addition, the mechanism of action of immune checkpoint inhibitors, new targets, and immunotherapeutic method are included.
An update on immune checkpoint inhibitor therapy as a single agent in ovarian, endometrial, and cervical cancer is presented. Guidelines for the use of immune checkpoint inhibitors are discussed, including those developed by ASCO.
The e-module presents the rationale and clinical trials exploring different immune checkpoint inhibitor combinations with chemotherapy, anti-angiogenics, PARP inhibitors, radiotherapy, and other immunotherapy agents in the different localisation and settings.
The advanced course in Ovarian Cancer Surgery aims to improve the training of surgeons and elevate the standards of knowledge on management of surgical aspects of gynaecological cancers treatment. The advanced theoretical lectures are complemented by explanatory step-by-step videos of surgical techniques by leading experts in the field.
The e-module contains the 4 following lectures. At the end there is a post-test to help you test and improve your knowledge. The number of test attempts is unlimited.
- Lecture 1: Immunotherapy in gynae-oncology: Why and how?
- Lecture 2: The development of checkpoint inhibitor combinations: Which future?
- Lecture 3: Checkpoint inhibitors in gynaecological cancers: What are the data?
- Lecture 4: How to detect and manage immunotherapy toxicity
You can watch the lectures in any order that you like but you will only have access to the module post-test after viewing all the lectures within the module.
After you have successfully completed the post-test, and the evaluation, you will be able to submit your feedback to the course and print out your certificate.
Obtain knowledge on basic science on immunotherapy, mechanism of action of immune checkpoint inhibitors, new targets, and immunotherapeutic methods.
Acquire comprehensive update of immune checkpoint inhibitor therapy as a single agent and in combinations with other treatments.
Learn on specific indication of immunotherapy in gynae cancers.
Understand how to manage the side effects of the checkpoints inhibitors.
All speakers have reported no potential conflict of interests.
|
Immunotherapy in gynae-oncology: Why and how?
|
|
|
The development of checkpoint inhibitor combinations: Which future?
|
|
|
Checkpoint inhibitors in gynaecological cancers: What are the data?
|
|
|
How to detect and manage immunotherapy toxicity
|
|
|
Final assessment & Evaluation
|
|
